Response

Hantavirus Cruise Outbreak: Focus on Intensive Supportive Care Protocols

Medical teams onboard the MV Hondius Andes and supporting facilities ashore are implementing rigorous supportive care protocols, with Extracorporeal Membrane Oxygenation (ECMO) emerging as a critical intervention for severe Hantavirus Cardiopulmonary Syndrome (HCPS) cases.

HCD

Hantavirus Cruise Desk

Outbreak Tracking Team · August 31, 2026 · 5 min read

Hantavirus Cruise Outbreak: Focus on Intensive Supportive Care Protocols

MV Hondius Andes: A Focus on Clinical Management

PRAIA, CAPE VERDE — As the MV Hondius Andes remains anchored off Praia, the clinical management of Hantavirus Cardiopulmonary Syndrome (HCPS) among those affected by the outbreak continues to be a paramount concern. Medical professionals, in consultation with international health organizations, are prioritizing intensive supportive care protocols to mitigate the severe respiratory and circulatory complications characteristic of HCPS. HCPS, caused by infection with certain hantaviruses, presents a bigly clinical challenge due to its rapid progression and high case fatality rate. Unlike many viral illnesses, there is currently no specific antiviral treatment or vaccine available for HCPS. As a result, medical intervention focuses entirely on managing symptoms and supporting vital organ functions as the body combats the infection.

Core Principles of Supportive Care

According to guidance from organizations like the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (US CDC), the cornerstone of HCPS management is aggressive supportive care, particularly for patients who develop pulmonary edema and circulatory collapse. This involves:

Oxygen Therapy and Ventilatory Support: Patients often experience rapid onset of respiratory distress due to fluid accumulation in the lungs. Early and aggressive oxygen supplementation is crucial. For severe cases, mechanical ventilation is often necessary to maintain adequate oxygenation and remove carbon dioxide. This can range from non-invasive positive pressure ventilation to conventional invasive mechanical ventilation. 2. Hemodynamic Monitoring and Management: The vascular leakage and myocardial dysfunction associated with HCPS can lead to cardiogenic shock. Close monitoring of blood pressure, heart rate, and fluid balance is essential. Intravenous fluids are administered cautiously to avoid exacerbating pulmonary edema, while vasopressors and inotropes may be used to support blood pressure and cardiac output. 3. Renal Support: Acute kidney injury can occur in severe HCPS cases. Dialysis may be required if renal function deteriorates bigly. 4. Electrolyte and Acid-Base Balance: careful attention to maintaining normal electrolyte levels and acid-base balance is critical given the systemic nature of the disease. 5. Infection Control: While HCPS is not typically transmissible person-to-person in an epidemic setting, standard infection control precautions are vital in healthcare environments to prevent secondary infections and protect medical staff. Though, the primary mode of transmission of hantaviruses is through inhalation of aerosolized rodent excreta.

The Role of ECMO

Extracorporeal Membrane Oxygenation (ECMO) has emerged as a life-saving intervention for patients with severe, refractory HCPS who don't respond to conventional mechanical ventilation and hemodynamic support. ECMO acts as an artificial lung and, in some cases, an artificial heart, providing temporary circulatory and/or respiratory support. For patients with HCPS, veno-venous ECMO (VV-ECMO) is primarily used to oxygenate blood and remove carbon dioxide, allowing the severely damaged lungs to rest and recover. Reports from medical teams involved in the Hondius Andes response indicate that access to ECMO capabilities has been a critical factor in managing the most severe cases. The logistical complexities of deploying and operating ECMO technology, especially in a mobile or temporary medical setting, highlight the bigly resource requirements for managing a severe hantavirus outbreak.

Drivers of Mortality

The high mortality rate associated with HCPS, which can range from 30% to 50% globally depending on the specific hantavirus strain and access to intensive care, is primarily driven by progressive cardiopulmonary failure. Specifically:

Refractory Pulmonary Edema: The rapid accumulation of fluid in the lungs impairs oxygen exchange, leading to acute respiratory distress syndrome (ARDS) and hypoxemia that may not be overcome by conventional ventilation. * Cardiogenic Shock: Myocardial depression and increased vascular permeability contribute to severe hypotension and organ hypoperfusion, leading to multi-organ failure. * Secondary Complications: Although less common, secondary bacterial infections, renal failure, or disseminated intravascular coagulation (DIC) can further complicate the clinical course and contribute to adverse outcomes. Early recognition of symptoms and rapid transfer to facilities equipped for intensive care, including mechanical ventilation and potentially ECMO, are paramount to improving patient outcomes. The ongoing efforts around the MV Hondius Andes underscore the global preparedness challenges posed by emerging infectious diseases with high fatality rates and limited specific treatments.